# A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

> **NCT06344091** · PHASE4 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 232 (estimated)

## Conditions studied

- Local Analgesia Via Infiltration

## Interventions

- **DRUG:** Bupivacaine Liposome Injection

## Key facts

- **NCT ID:** NCT06344091
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-21
- **Primary completion:** 2026-09-28
- **Final completion:** 2026-10-12
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344091, "A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06344091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*